Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.336ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.336ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.9EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.1.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.9ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5.1.9ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.5.1.9EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.1.9EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.1.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.1.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.317EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.317EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.317ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.317ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.317EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.317EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.317ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.317ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.397EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.397EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.397ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.397ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.397EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.397EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.397ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.397ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.277EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.277EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.277ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.277ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.277EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.277EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.277ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.277ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.294EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.294EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.294ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.294ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.294EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.294EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.294ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.294ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used